Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Gilman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Pharmacokinetics|July 1, 1990
Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implicationsJ T Gilman
Journal of Child Neurology|October 1, 1994
Developmental principles of antiepileptic drug therapyJ T Gilman
The Annals of Pharmacotherapy|February 1, 1995
Lamotrigine: an antiepileptic agent for the treatment of partial seizuresJ T Gilman
Clinical Pharmacy|September 1, 1991
Valproic acid hepatotoxicity in adults and older childrenJ T Gilman
DICP : the Annals of Pharmacotherapy|October 1, 1991
Carbamazepine dosing for pediatric seizure disorders: the highs and lowsJ T Gilman
Drug Intelligence & Clinical Pharmacy|June 1, 1986
Inadequacy of FDA dosing guidelines for theophylline use in neonatesJ T Gilman, P Gal
CNS Drugs|August 14, 2016
Childhood Epilepsy : Current Therapeutic RecommendationsJ T Gilman, M Duchowny
The Annals of Pharmacotherapy|November 1, 1993
Drug disposition in neonates with patent ductus arteriosusP Gal, J T Gilman
Clinical Pharmacokinetics|July 1, 1992
Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontierJ T Gilman, P Gal
Epilepsia|November 3, 1998
Allergic hypersensitivity to antiepileptic drugs: past, present, and futureJ T Gilman, M Duchowny
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|July 1, 1990
Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implicationsJ T Gilman
Journal of Child Neurology|October 1, 1994
Developmental principles of antiepileptic drug therapyJ T Gilman
The Annals of Pharmacotherapy|February 1, 1995
Lamotrigine: an antiepileptic agent for the treatment of partial seizuresJ T Gilman
Clinical Pharmacy|September 1, 1991
Valproic acid hepatotoxicity in adults and older childrenJ T Gilman
DICP : the Annals of Pharmacotherapy|October 1, 1991
Carbamazepine dosing for pediatric seizure disorders: the highs and lowsJ T Gilman
Drug Intelligence & Clinical Pharmacy|June 1, 1986
Inadequacy of FDA dosing guidelines for theophylline use in neonatesJ T Gilman, P Gal
CNS Drugs|August 14, 2016
Childhood Epilepsy : Current Therapeutic RecommendationsJ T Gilman, M Duchowny
The Annals of Pharmacotherapy|November 1, 1993
Drug disposition in neonates with patent ductus arteriosusP Gal, J T Gilman
Clinical Pharmacokinetics|July 1, 1992
Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontierJ T Gilman, P Gal
Epilepsia|November 3, 1998
Allergic hypersensitivity to antiepileptic drugs: past, present, and futureJ T Gilman, M Duchowny
Pageof 3